Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization

Laboratory Investigation

Volumn 81, Issue 12, 2001, Pages 1639-1645

  Corvi, Raffaella ^a   Martinez Alfaro, Minerva ^b   Harach, H Ruben ^c   Zini, Michele ^d   Papotti, Mauro ^e   Romeo, Giovanni ^b  

^a JOINT RESEARCH CENTRE   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c Service of Pathology   (Argentina)

^d S MARIA NUOVA HOSPITAL   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CANCER SIZE; CARCINOGENESIS; CHROMOSOME 10Q; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; INTERPHASE; MALE; ONCOGENE RET; PRIORITY JOURNAL; PROTO ONCOGENE; SOMATIC MUTATION; THYROID PAPILLARY CARCINOMA; TRISOMY; TRISOMY 10;

EID: 0035209830     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780377     Document Type: Article

References (33)

1. Thyroid papillary carcinoma and its variants
2. Multiple significance tests and the Bonferroni correction
3. Frequent activation of ret proto-oncogene by fusion with a new activating gene in papillary thyroid carcinomas
4. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A
5. The RET proto-oncogene induces apoptosis: A novel mechanism for Hirschsprung disease
6. RET receptor expression in thyroid follicular epithelial cell-derived tumors
7. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH
8. MYCN is retained in single copy at chromosome band during amplification in human neuroblastoma cells
9. RET/PCM-1: A novel fusion gene in papillary thyroid carcinoma
10. RET rearrangements in familial papillary thyroid carcinomas
11. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer
12. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
13. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study
14. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method
15. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5
16. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas
17. Ret oncogene activation in papillary thyroid carcinoma: Prevalence and implication on the histological parameters
18. Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies
19. Enzymatic synthesis of biotin-labeled polynucleotides: Novel nucleic acid affinity probes
20. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis
21. Fusion of a novel gene. ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma
22. Estimates of the worldwide incidence of 25 major cancers in 1990
23. RET mutations in human disease
24. The physical map of the human RET proto-oncogene
25. Translocation t(10;14)(q11.2: q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma
26. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice
27. Sporadic ret-rearranged papillary carcinoma of the thyroid: A subset of slow growing, less aggressive thyroid neoplasms?
28. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia
29. Ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: Implications for metastatic potential?
30. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy
31. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes
32. Papillary microcarcinoma of the thyroid. 179 cases reported since 1973
33. RET/PTC oncogene activation is an early event in thyroid carcinogenesis